Check out TBRC’s sale today for
The blood transfusion diagnostics market consists of sales of blood transfusion diagnostics devices and related services. The related services here includes only installation and maintenance services offered by equipment manufacturers. Blood transfusion diagnostics are the devices which used to conduct tests before transfusion of blood from donor recipient such as blood grouping disease screening.
Global Blood Transfusion Diagnostics Market Size And Drivers:
The global blood transfusion diagnostics market is expected to grow from $3.82 billion in 2020 to $4.18 billion in 2021 at a compound annual growth rate (CAGR) of 9.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The blood transfusion diagnostics market is expected to reach $5.28 billion in 2025 at a CAGR of 6%. Patients undergoing surgical procedures need blood transfusion to replace the lost blood during the procedure.
Request For A Sample For The Global Blood Transfusion Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp
Trends In The Global Blood Transfusion Diagnostics Market
The growing demand for advanced diagnostic measures and growing prevalence of infectious diseases associated with pathogens such as bacteria & viruses increase the preference for nucleic acid amplification testing (NAAT/NAT) to increase blood safety, improve efficiency and reduce turnaround time of the results. NAT is a technique that helps detect a particular nucleic acid, virus, or bacteria which acts as a pathogen in blood, tissue, or urine. NAT is highly sensitive and specific for viral nucleic acids and amplifies the region of targeted viral DNA and detects them earlier than the other traditional methods and narrows the period of infectious diseases. For example, XCRP Diagnostic Inc. and Luminex Corporations entered into a licensing agreement of XCR Diagnostic's Xtreme Chain Reaction Nucleic Acid Amplification Technology. In this deal, Luminex got the exclusive rights to use the XCR Diagnostic's NAAT technology for their future molecular diagnostic portfolio.
Global Blood Transfusion Diagnostics Market Segments:
The global blood transfusion diagnostic market is further segmented –
By Type: Instruments and Kits, Reagents, Others
By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test
By Application: Blood Grouping, Disease Screening
By Geography: The global blood transfusion market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Blood Transfusion Diagnostics Market At:
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Blood Transfusion Diagnostics Global Market Report 2021 is one of a series of new reports from that provides blood transfusion diagnostics market overviews, analyzes and forecasts market size and growth for the global blood transfusion diagnostics market, blood transfusion diagnostics market share, blood transfusion diagnostics market players, blood transfusion diagnostics market segments and geographies, blood transfusion diagnostics market’s leading competitors’ revenues, profiles and market shares. The blood transfusion diagnostics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
